227 related articles for article (PubMed ID: 1723797)
1. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
Gough B; Ali SF; Slikker W; Holson RR
Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
Gough B; Imam SZ; Blough B; Slikker W; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116
[TBL] [Abstract][Full Text] [Related]
3. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study.
Hiramatsu M; Cho AK
Neuropharmacology; 1990 Mar; 29(3):269-75. PubMed ID: 1691459
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.
Hiramatsu M; DiStefano E; Chang AS; Cho AK
Eur J Pharmacol; 1991 Nov; 204(2):135-40. PubMed ID: 1725282
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
[TBL] [Abstract][Full Text] [Related]
7. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.
Nash JF; Nichols DE
Eur J Pharmacol; 1991 Jul; 200(1):53-8. PubMed ID: 1722755
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
[TBL] [Abstract][Full Text] [Related]
9. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.
Heidbreder C; Gewiss M; De Potter W; De Witte P
Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678
[TBL] [Abstract][Full Text] [Related]
10. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.
Yamamoto BK; Spanos LJ
Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922
[TBL] [Abstract][Full Text] [Related]
11. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
Bowyer JF; Gough B; Slikker W; Lipe GW; Newport GD; Holson RR
Pharmacol Biochem Behav; 1993 Jan; 44(1):87-98. PubMed ID: 8094252
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
13. In vivo output of dopamine and metabolites from the rat caudate nucleus as estimated with push-pull perfusion on-line with HPLC-EC in unrestrained, conscious rats. I. Chromatographic and biological validation.
Chen JC; Rhee KK; Beaudry DM; Ramirez VD
Neuroendocrinology; 1984 May; 38(5):362-70. PubMed ID: 6203048
[TBL] [Abstract][Full Text] [Related]
14. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
Nash JF
Life Sci; 1990; 47(26):2401-8. PubMed ID: 1979830
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W
Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472
[TBL] [Abstract][Full Text] [Related]
16. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
Miyake H; Chiueh CC
Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372
[TBL] [Abstract][Full Text] [Related]
17. In vivo on-line HPLC-microdialysis: simultaneous detection of monoamines and their metabolites in awake freely-moving rats.
Chaurasia CS; Chen CE; Ashby CR
J Pharm Biomed Anal; 1999 Mar; 19(3-4):413-22. PubMed ID: 10704106
[TBL] [Abstract][Full Text] [Related]
18. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
Johnson MP; Huang XM; Nichols DE
Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189
[TBL] [Abstract][Full Text] [Related]
19. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
Schmidt CJ; Wu L; Lovenberg W
Eur J Pharmacol; 1986 May; 124(1-2):175-8. PubMed ID: 2424776
[TBL] [Abstract][Full Text] [Related]
20. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine.
Bailey BA; Philips SR; Boulton AA
Neurochem Res; 1987 Feb; 12(2):173-8. PubMed ID: 2437473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
